Additional European Equity News
SourceNewsquawk
SectionGlobal News
AstraZeneca (AZN LN) - Tagrisso with the addition of chemotherapy approved in the EU as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer. (AstraZeneca)
Atos (ATO FP) - Secured short-term funding via a syndication agreement, under the EUR 1.5bln term loan of the Co.. Restructuring operations to be implemented in H2. (Newswires)
Saab (SAAB SS) - Co's new navigation system has been approved for use within the Panama Canal. (Newswires)
Shell (SHEL LN) - Co. expects a non-cash post tax impairment of USD 1.5-2.0bln in Q2. Q2: Upstream production seen at 1720-1820k/BOEPD; Integrated gas production 940-980k/BOEPD. (Shell)